株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管向け画像装置:医療機器のパイプライン評価

Cardiovascular Imaging Equipment - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 347931
出版日 ページ情報 英文 118 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.80円で換算しております。
Back to Top
心血管向け画像装置:医療機器のパイプライン評価 Cardiovascular Imaging Equipment - Medical Devices Pipeline Assessment, 2017
出版日: 2017年08月01日 ページ情報: 英文 118 Pages
概要

当レポートでは、世界の心血管向け画像装置市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など)、といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 心血管向け画像装置市場の概要

第3章 心血管向け画像装置市場:治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 心血管向け画像装置の企業:治験段階別のパイプライン製品
  • 心血管向け画像装置:治験段階別のパイプライン製品

第5章 心血管向け画像装置市場:企業・製品の概要

  • Beth Israel Deaconess Medical Center, Inc.
    • パイプライン製品および進行中の治験の概要
  • Boston Scientific Corporation
  • CardioPaint
  • Colibri Technologies Incorporated
  • FMI Technologies, Inc.
  • Illumasonix LLC
  • Medistim ASA
  • Nano4Imaging GmbH
  • Perinatronics Medical systems Inc
  • Philips Healthcare
  • Purdue University
  • Siemens Healthcare
  • St. Jude Medical, Inc.
  • Sync-Rx, Ltd.
  • University of Colorado
  • Vibronix Inc.
  • Volcano Corporation
  • Wisconsin Institute of Nuclear Systems
  • XCounter AB

第6章 心血管向け画像装置市場:昨今の動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0388EPD

GlobalData's Medical Devices sector report, "Cardiovascular Imaging Equipment - Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiovascular Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiovascular Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiovascular Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiovascular Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Cardiovascular Imaging Equipment Overview 7

3 Products under Development 8

  • 3.1 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 8
  • 3.2 Cardiovascular Imaging Equipment - Pipeline Products by Territory 9
  • 3.3 Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path 10
  • 3.4 Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date 11
  • 3.5 Cardiovascular Imaging Equipment - Ongoing Clinical Trials 12

4 Cardiovascular Imaging Equipment - Pipeline Products under Development by Companies 13

  • 4.1 Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development 13
  • 4.2 Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 14

5 Cardiovascular Imaging Equipment Companies and Product Overview 15

  • 5.1 Arineta Ltd. Company Overview 15
    • 5.1.1 Arineta Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Beth Israel Deaconess Medical Center Inc Company Overview 16
    • 5.2.1 Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 CardioPaint Company Overview 17
    • 5.3.1 CardioPaint Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Columbia University Company Overview 18
    • 5.4.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Evena Medical, Inc. Company Overview 20
    • 5.5.1 Evena Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 FMI Technologies, Inc. Company Overview 21
    • 5.6.1 FMI Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.7 GE Healthcare LLC Company Overview 22
    • 5.7.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.8 Illumasonix LLC Company Overview 25
    • 5.8.1 Illumasonix LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.9 King's College London Company Overview 26
    • 5.9.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.10 Medistim ASA Company Overview 27
    • 5.10.1 Medistim ASA Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.11 Nano4Imaging GmbH Company Overview 30
    • 5.11.1 Nano4Imaging GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.12 Perinatronics Medical systems Inc Company Overview 31
    • 5.12.1 Perinatronics Medical systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.13 Purdue University Company Overview 32
    • 5.13.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.14 Terumo Corp Company Overview 33
    • 5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.15 University Health Network Company Overview 34
    • 5.15.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.16 University of Colorado Company Overview 35
    • 5.16.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.17 University of Glasgow Company Overview 36
    • 5.17.1 University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.18 Vibronix Inc. Company Overview 37
    • 5.18.1 Vibronix Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.19 Volcano Corp Company Overview 38
    • 5.19.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.20 Wisconsin Institute of Nuclear Systems Company Overview 44
    • 5.20.1 Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 44

6 Cardiovascular Imaging Equipment- Recent Developments 45

  • 6.1 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 45
  • 6.2 Jun 21, 2017: HeartFlow Names Former J&J Chairman and CEO William C. Weldon Chairman of the Board 47
  • 6.3 Jun 20, 2017: DIA Imaging Analysis Ltd is the New Name of DiACardio, Expanding its Vision in Medical Imaging 47
  • 6.4 Jun 19, 2017: Conavi Medical Welcomes Peter Wehrly to the Board of Directors 48
  • 6.5 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 48
  • 6.6 Jun 07, 2017: Calgary Scientific Optimizes Partner and Customer Relationships with Updates to Leadership Team 49
  • 6.7 Jun 01, 2017: HeartFlow Names Healthcare Industry Veteran Michael Buck as Executive Vice President and Chief Commercial Officer 49
  • 6.8 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 50
  • 6.9 May 23, 2017: KARL STORZ Wins Inter Partes Review Trial Invalidating Novadaq Patent 53
  • 6.10 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 53
  • 6.11 May 03, 2017: NOVADAQ Announces First Quarter 2017 Financial Results 54
  • 6.12 May 01, 2017: Conavi Medical Receives 510(k) Clearance from the FDA for the Foresight Intracardiac Echocardiography (ICE) System now Equipped with Color Doppler, 2D and 3D Measurements, and Enhanced 3D Visualization 55
  • 6.13 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 55
  • 6.14 Apr 27, 2017: Medistim: Results for the First Quarter 2017 56
  • 6.15 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 60
  • 6.16 Apr 20, 2017: Applications Open for ASRT Foundation and Toshiba Medical Safety FiRsT Grant Program 60
  • 6.17 Mar 28, 2017: LiDCO Group Announces Final Results 61
  • 6.18 Mar 17, 2017: Philips showcases data-driven cardiology solutions at 2017 American College of Cardiology Conference 62
  • 6.19 Mar 16, 2017: Siemens Healthineers and HeartFlow Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs 63
  • 6.20 Mar 13, 2017: Conavi Medical Announces Health Canada Approval of the Foresight Intracardiac Echocardiography System 63
  • 6.21 Mar 10, 2017: IMRIS, Deerfield Imaging appoints Robert C. Korn as Senior Vice President - Global Sales and Marketing 64
  • 6.22 Mar 01, 2017: LIDCO GROUP: Board Changes 64
  • 6.23 Feb 28, 2017: NOVADAQ Announces Fourth Quarter And Full Year 2016 Financial Results 66
  • 6.24 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 67
  • 6.25 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 70
  • 6.26 Feb 20, 2017: Medistim: Results for the Fourth Quarter 2016 70
  • 6.27 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 71
  • 6.28 Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 71
  • 6.29 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 73
  • 6.30 Jan 10, 2017: Lidco Group: Appointment of Head of North America 75
  • 6.31 Jan 10, 2017: NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue And Issues 2017 Revenue Guidance 75
  • 6.32 Dec 14, 2016: Stereotaxis Launches Interface Between Niobe Es System And Philips' State-of-the-art X-ray System 76
  • 6.33 Dec 12, 2016: VIDA Diagnostics names new COO 76
  • 6.34 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 77
  • 6.35 Nov 21, 2016: Toshiba Medical Angiography Systems Help Clinicians Maximize Flexibility, Minimize Exposure and Optimize Image Quality in Interventional Radiology 80
  • 6.36 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 81
  • 6.37 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 81
  • 6.38 Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 82
  • 6.39 Nov 02, 2016: NOVADAQ Reports Third Quarter 2016 Financial Results 83
  • 6.40 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 84
  • 6.41 Oct 30, 2016: ILUMIEN III Clinical Trial Results from St. Jude Medical Demonstrate Important Findings with Advanced Intravascular Imaging Technology 85
  • 6.42 Oct 30, 2016: Study Examines use of Optical Coherence Tomography Compared to Intravascular Ultrasound and Angiography to Guide Coronary Stent Implantation 86
  • 6.43 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 87
  • 6.44 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 89
  • 6.45 Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference 89
  • 6.46 Oct 20, 2016: Medistim: Results for the Third Quarter 2016 90
  • 6.47 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 92
  • 6.48 Oct 11, 2016: LiDCO GROUP: Interim Results for the six months ended 31 July 2016 94
  • 6.49 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 98
  • 6.50 Sep 27, 2016: Stereotaxis Announces Recruitment of Highly Experienced Board Members 99
  • 6.51 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 99
  • 6.52 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 100
  • 6.53 Aug 24, 2016: Medistim: 2nd quarter and 1st half report for 2016 103
  • 6.54 Aug 23, 2016: Philips showcases full suite of cardiology solutions for personalized approach to prevention, diagnosis and treatment of cardiovascular disease at ESC Congress 2016 107
  • 6.55 Aug 10, 2016: Arineta CT FDA Clearance 108
  • 6.56 Aug 09, 2016: Stereotaxis Reports 2016 Second Quarter Financial Results 109
  • 6.57 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program 111
  • 6.58 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 111
  • 6.59 Jul 27, 2016: NOVADAQ Reports Second Quarter 2016 Financial Results 113
  • 6.60 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) 114

7 Appendix 115

  • 7.1 Methodology 115
  • 7.2 About GlobalData 118
  • 7.3 Contact Us 118
  • 7.4 Disclaimer 118

List of Tables

1.1 List of Tables

  • Table 1: Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 8
  • Table 2: Cardiovascular Imaging Equipment - Pipeline Products by Territory 9
  • Table 3: Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path 10
  • Table 4: Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date 11
  • Table 5: Cardiovascular Imaging Equipment - Ongoing Clinical Trials 12
  • Table 6: Cardiovascular Imaging Equipment Companies - Pipeline Products by Stage of Development 13
  • Table 7: Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 14
  • Table 8: Arineta Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 9: SpotLight CT - Product Status 15
  • Table 10: SpotLight CT - Product Description 15
  • Table 11: Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 12: XFM Interventional Guidance System - Product Status 16
  • Table 13: XFM Interventional Guidance System - Product Description 16
  • Table 14: CardioPaint Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 15: CardioPaint Device - Product Status 17
  • Table 16: CardioPaint Device - Product Description 17
  • Table 17: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 18: Electromechanical Wave Imaging System - Product Status 18
  • Table 19: Electromechanical Wave Imaging System - Product Description 18
  • Table 20: Myocardial Elastography - Ischemia - Product Status 19
  • Table 21: Myocardial Elastography - Ischemia - Product Description 19
  • Table 22: Evena Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 23: Eyes-On Glasses 3.0 - Product Status 20
  • Table 24: Eyes-On Glasses 3.0 - Product Description 20
  • Table 25: FMI Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 26: ScintiStar Cardiac LPX PET/CT - Product Status 21
  • Table 27: ScintiStar Cardiac LPX PET/CT - Product Description 21
  • Table 28: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 29: ViosWorks - Product Status 22
  • Table 30: ViosWorks - Product Description 22
  • Table 31: GE Healthcare LLC - Ongoing Clinical Trials Overview 23
  • Table 32: ViosWorks - The Effectiveness of 4D Image Acquisition and Post-processing with Vios Works: A Phase Design Prospective Clinical Trial to Assess 4D Software Produced by GE and Arterys for Evaluating Cardiac Disease 24
  • Table 33: Illumasonix LLC Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 34: Echo PIV - Product Status 25
  • Table 35: Echo PIV - Product Description 25
  • Table 36: King's College London Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 37: Imaging Guidance System -Arrhythmia - Product Status 26
  • Table 38: Imaging Guidance System -Arrhythmia - Product Description 26
  • Table 39: Medistim ASA Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 40: MiraQ Cardiac - Product Status 27
  • Table 41: MiraQ Cardiac - Product Description 28
  • Table 42: MiraQ Ultimate - Product Status 28
  • Table 43: MiraQ Ultimate - Product Description 29
  • Table 44: Nano4Imaging GmbH Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 45: GraftVision - Product Status 30
  • Table 46: GraftVision - Product Description 30
  • Table 47: Perinatronics Medical systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 48: MRI ECG Trigger - Product Status 31
  • Table 49: MRI ECG Trigger - Product Description 31
  • Table 50: Purdue University Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 51: 3D Visualization Laser - Product Status 32
  • Table 52: 3D Visualization Laser - Product Description 32
  • Table 53: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 54: Cardiovascular Imaging System - Product Status 33
  • Table 55: Cardiovascular Imaging System - Product Description 33
  • Table 56: University Health Network Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 57: Forward-Viewing Intravascular Imaging Device - Product Status 34
  • Table 58: Forward-Viewing Intravascular Imaging Device - Product Description 34
  • Table 59: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 60: Intra-Cardiac Camera System - Product Status 35
  • Table 61: Intra-Cardiac Camera System - Product Description 35
  • Table 62: University of Glasgow Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 63: SERS-Based System - Product Status 36
  • Table 64: SERS-Based System - Product Description 36
  • Table 65: Vibronix Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 66: Intravascular Photoacoustic System - Product Status 37
  • Table 67: Intravascular Photoacoustic System - Product Description 37
  • Table 68: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 69: Co-Reg + i/FFR - Product Status 38
  • Table 70: Co-Reg + i/FFR - Product Description 38
  • Table 71: FM Co-Reg - Product Status 39
  • Table 72: FM Co-Reg - Product Description 39
  • Table 73: Integrated IFR/CFR Platform - Product Status 39
  • Table 74: Integrated IFR/CFR Platform - Product Description 40
  • Table 75: Integrated OCT Platform - Product Status 40
  • Table 76: Integrated OCT Platform - Product Description 40
  • Table 77: IVI Co-Registration Platform - Product Status 41
  • Table 78: IVI Co-Registration Platform - Product Description 41
  • Table 79: LVOCT System - Product Status 41
  • Table 80: LVOCT System - Product Description 42
  • Table 81: OMNI Multi-Modality FM System - Product Status 42
  • Table 82: OMNI Multi-Modality FM System - Product Description 42
  • Table 83: Omni+ - Product Status 43
  • Table 84: Omni+ - Product Description 43
  • Table 85: Volcano OCT System - Second Generation - Product Status 43
  • Table 86: Volcano OCT System - Second Generation - Product Description 43
  • Table 87: Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 88: PC VIPR - Product Status 44
  • Table 89: PC VIPR - Product Description 44
  • Table 90: Glossary 117

List of Figures

1.2 List of Figures

  • Figure 1: Cardiovascular Imaging Equipment - Pipeline Products by Stage of Development 8
  • Figure 2: Cardiovascular Imaging Equipment - Pipeline Products by Territory 9
  • Figure 3: Cardiovascular Imaging Equipment - Pipeline Products by Regulatory Path 10
  • Figure 4: Cardiovascular Imaging Equipment - Pipeline Products by Estimated Approval Date 11
  • Figure 5: Cardiovascular Imaging Equipment - Ongoing Clinical Trials 12
Back to Top